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This report describes studies on the mechanism of eosinophilia in blood and bone
marrow ofa patient with untreated Addison's disease.
CASE REPORT
A 21-year-old man was admitted to hospital because ofdiarrhea, vomiting, and ab-
dominal pain. The illness had begun 3 years earlier when he first felt excessive fatigue
and noticed areas ofvitiligo. He had attacks ofvomiting, lasting about a week, recur-
ring every few months. He lost weight and had to give up his work. He had no history
of allergies. On admission to hospital, he was dehydrated and thin, with generalized
pigmentation including the palmar creases, but there was no pigmentation ofmucous
membranes. The tips of the fingers, skin over the hips, and nipples showed vitiligo.
Systolic blood pressure was 70 mm Hg. He had no fever. A clinical diagnosis of Ad-
dison's disease was made.
Hemoglobin was 14 g%, leukocyte count 7000/mm3, with 800 eosinophils/mm3,
ESR 28. ECG showed flat T waves in the chest leads. Urea was initially 68 mg/100
ml, and returned to normal after he was rehydrated. Blood electrolytes were normal.
Chest X ray showed a small tubular heart. Plasma cortisol levels were low, 7-9
tsg/I00 ml, with no diurnal variation or increase after injection of0.25 mgofan adre-
nocorticotrophic hormone analog, Synacthen (Ciba). The serum contained "yG anti-
bodies to human adrenal tissue at a dilution of 1/20. There was no evidence ofother
endocrine disorder. There were no intrinsic factor antibodies, and the stomach
produced normal amounts of acid in response to gastrin stimulation. The serum pro-
tein-bound iodine and vitamin BI2 levels were normal. The Mantoux test was negative
at 1/1000. The stool did not contain parasites or ova.
Eosinophil production and half-life. Direct blood eosinophil counts were done by
the method of Discombe (1) on venous blood before and after giving Synacthen, 0.25
mg intramuscularly, and cortisone, 25 mg orally, as shown in Fig. 1. There was no
alteration in blood eosinophil counts in response to Synacthen; however, 25 mg of
cortisone reduced the blood eosinophil count from 780 to 230/mm3 4 hr later. When
the patient began taking cortisone, 12.5 mg orally twice daily, the blood eosinophil
level remained normal.
Bone marrow biopsies were done 6 hr before and 3 days after cortisone treatment
was begun. The patient had given his full consent when the experimental character
and nature of the biopsies had been explained. The bone marrow was taken from the
sternum and put directly into a culture medium at 370C containing 8 ml of Parker
199 (Wellcome), 2 ml ofisotonic phosphate buffer at pH 7.4, 1 ml of50% glucose, and
1 ml of unheated isologous fresh serum taken 1.5 hr before sternal puncture, with 1
unit of heparin/ml. Two microcuries of [3H]thymidine 15.6 Ci/mmole (The
Radiochemical Centre, Amersham) in 0.1 ml of saline was added, and the marrow
cells were left at 370 C for 0.5 hr with intermittent shaking. Cells were then washed
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FIG. 1. Blood eosinophil counts in the untreated patient with Addison's disease. The raised counts were
not reduced by ACTH analog, but after cortisone the count fell rapidly to normal.
four times and concentrated by centrifugation in a capillary tube, using a
microhematocrit centrifuge (Hawksley). The layer ofwhite cells was put in six drops
of culture medium and centrifuged onto six slides using a Cytocentrifuge (Shandon,
Ltd.). Autoradiographs were prepared using a dipping technique, and after 3 weeks
the films were developed and the slides were stained with hemotoxylin and Biebrich
scarlet at pH 9.5. Results ofthe bone marrow studies are shown in Table 1.
COMMENT
In this patient, steroids reduced the number of blood eosinophils within 4 hr by
70%. The rate of fall was exponential, which favors the concept of random loss of
eosinophils from the blood irrespective of their age, as described by Thompson and
van Furth (2) for mouse monocytes following an injection ofsteroids. Calculations by
the method of van Furth and Cohn (3) indicated that during this 4-hr period, the half-
life of eosinophils in the patient's circulation was 2.4 hr. Presumably the mechanism
of this acute eosinopenic response is an intravascular shift ofeosinophils or increased
migration into tissues.
Marrow content of eosinophils declined by half, 3 days after steroids were begun,
and the proportion of marrow eosinophils in DNA synthesis (S phase) declined by
two-thirds. This is compatible with the possibility that steroids had decreased mar-
row eosinophil production, as the diminished labeling indicated fewer eosinophils in
the cell cycle, possibly combined with S phase occupying a smaller proportion ofthe
cell cycle time. Inasmuch as kinetic studies on rat bone marrow eosinophils have
shown that alterations in production take 2 days to affect blood levels (4), it seems
likely that the decrease in blood eosinophils in this patient came about by two actions
of steroids: first, a direct effect on the circulating eosinophils and, later, a reduced
TABLE
Marrow Eosinophils a
Before steroids After steroids
Eosinophils among 2000 nucleated marrow cells 118 46
(5.9%) (2.3%)
Number oflabeled eosinophils among 1000 marrow eosinophils 110 40
(11%) (4%)
Marrow eosinophils before and 3 days after the patient with Addison's disease was treated with
cortisone. Both the content ofmarrow eosinophils and their DNA synthetic activity were reduced.
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rate of eosinophil production. The effect on eosinophil production may be mediated
through an action on lymphocytes, as other studies in this laboratory have provided
evidence that eosinophilia is mediated by lymphocytes and that agents which affect
body stores oflymphocytes can block the eosinophil response to parasitic invasion (5,
6).
An eosinophilia is occasionally found in Addison's disease. Hills et al. (7) found
that 4 of 26 patients with untreated Addison's disease had eosinophil counts greater
than 500/mm3. They assumed that the eosinophilia was due to the low levels ofcircu-
lating steroids, but, if this is so, it is surprising that eosinophilia is not a constant fea-
ture of Addison's disease. Autoantibodies to adrenal tissue have been described in
50% of patients with Addison's disease (8, 9). West (10) described a patient with Ad-
dison's disease, due to tuberculosis, who had an eosinopenia. The patient described
here had both an eosinophilia and adrenal antibodies, raising the possibility that an
eosinophilia greater than 500/mm3 before treatment may occur in the autoallergic
form of Addison's disease. We have been unable to find any other reports in which
pretreatment eosinophil counts have been done in patients shown to have adrenal
autoantibodies. Eosinophil counts after treatment has begun would not be helpful, as
steroids affect the eosinophil count by the mechanism described in this patient.
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